Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 34 M34 M35 M40 M38 M43 M 156 M Research & development —————— — Operating income 257 M223 M349 M196 M249 M185 M 979 M Non-Operating Income, Total -91 M-92 M-86 M-95 M-86 M67 M -200 M Interest expense, net of interest capitalized 119 M124 M128 M141 M142 M143 M 554 M Non-Operating Income, excl. Interest Expenses -207 M-215 M-214 M-239 M-232 M-78 M -763 M Unusual income/expense -3 M-1 M03 M4 M2 M 9 M Pretax income 166 M131 M263 M101 M163 M118 M 645 M Equity in earnings 13 M10 M18 M19 M22 M43 M 102 M Taxes -47 M-43 M-18 M-41 M-61 M52 M -68 M Non-controlling/minority interest —————— — After tax other income/expense -1 M2 M-3 M-25 M15 M— — Net income before discontinued operations 213 M174 M281 M142 M224 M170 M 817 M Discontinued operations —————— — Net income 213 M174 M281 M142 M224 M170 M 817 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 213 M174 M281 M142 M224 M170 M 817 M Basic earnings per share (Basic EPS) 0.830.681.090.550.870.66 3.17 Diluted earnings per share (Diluted EPS) 0.830.681.090.540.870.65 3.15 Average basic shares outstanding 256.8 M256.9 M257 M257 M257.4 M257.9 M — Diluted shares outstanding 257.2 M257.3 M257.8 M257.8 M258.8 M259.9 M — EBITDA 468 M431 M560 M412 M472 M405 M 1.85 B EBIT 257 M223 M349 M196 M249 M185 M 979 M Cost of revenue 158 M151 M166 M150 M159 M155 M 630 M Other cost of goods sold —————— — Depreciation & amortization (cash flow) 211 M208 M211 M216 M223 M220 M 870 M